BOSTON, May 10, 2017 /PRNewswire/ — Intrinsic Therapeutics, Inc. a medical device company that has developed a product to improve outcomes in lumbar discectomy patients, announced today that it recently closed a $49 million round of financing. The financing included a $28 million equity…
May 10, 2017 at 02:21PM
from
No comments:
Post a Comment